HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19.

Abstract
In the hospital department dedicated to COVID-19-patient, infection prevention and control measures were upgraded. Therefore, the cross-transmission of other micro-organisms was thought unlikely to occur. However, we report an outbreak of NDM-5-producing Escherichia. coli in a 12-beds ICU dedicated to COVID-19 patients. This outbreak involved 6 patients of which 5 were asymptomatic carriers and 1 was infected. Several findings might have contributed to cross-transmission including the multiple-bedroom configuration of the department, uncomplete compliance for standard and contact precautions, overwork due to the burden of the disease, lack of training of staff for the care of ICU-patients, and misuse of gloves. Furthermore, as infection prevention and control measures were thought to be applied, contact patients were not screened for eXDR carriage. Applying rigorously standard and contact precautions and performing screening in contact patients when indicated must be the rules in COVID-19 wards.
AuthorsEric Farfour, Marion Lecuru, Laurent Dortet, Morgan Le Guen, Charles Cerf, Françoise Karnycheff, Rémy A Bonnin, Marc Vasse, Philippe Lesprit, SARS-CoV-2 Hospital Foch study group
JournalAmerican journal of infection control (Am J Infect Control) Vol. 48 Issue 12 Pg. 1533-1536 (12 2020) ISSN: 1527-3296 [Electronic] United States
PMID33011336 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • COVID-19 (microbiology, transmission)
  • Carbapenem-Resistant Enterobacteriaceae
  • Coinfection (epidemiology, microbiology, transmission)
  • Cross Infection (epidemiology, microbiology, transmission)
  • Disease Outbreaks
  • Enterobacteriaceae Infections (epidemiology, microbiology, transmission)
  • Female
  • France (epidemiology)
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: